EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modern approaches in asthma management: Revolutionizing severe asthma treatment with biologics

Shamail Zia, Farozaan Shamail, Fazail Zia, Vardah Zia, Shamsa Naeem

Journal of the Pakistan Medical Association · 25.05.2026 · 76 (06) · 931-937

DOI: 10.47391/jpma.23160 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 25.05.2026. Verfasst von Shamail Zia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Noor e Zia Consultant Teleclinics, Karachi, Pakistan. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents, Biological Products. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There have been advancements in the management of asthma among adults over the last two decades. The type 2 processes of airways inflammation and the use of type 2 biomarkers fractional expired nitric oxide and eosinophils have been further illuminated owing to such advancements. Moreover, epithelial cells are appearing as noteworthy elements for inflammation via the production of alarmins to start the local injury along with downstream pathways. Five new biologics have revolutionised severe asthma therapy apart from omalizumab, which are mepolizumab, benralizumab, reslizumab, dupilumab and tezepelumab. These biologics prevent the exacerbations significantly, thereby sparing the use of systemic corticosteroids and their adverse effects. For both rescue and maintenance therapies, the available guidelines prove the efficacy of inhaled corticosteroids and long-acting beta-2 agonists, like formoterol. Future guidelines ought to incorporate phenotype/endotype-focused management to acquire further precision-directed therapy. Key Words: Asthma management, Phenotype/endotype, T2 inflammation and biologics, Adult asthma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAnti-Asthmatic AgentsBiological ProductsHumansAntibodies, Monoclonal, HumanizedAdrenal Cortex HormonesOmalizumabAdrenergic beta-2 Receptor Agonists

Stichwörter der Autor:innen

Asthma management, Phenotype/endotype, T2 inflammation and biologics, Adult ast…

Substanzen

Anti-Asthmatic AgentsBiological ProductsAntibodies, Monoclonal, HumanizedmepolizumabAdrenal Cortex HormonesOmalizumabbenralizumabdupilumabreslizumabtezepelumab

Autor:innen und Institutionen

  • Department of Pathology, Noor e Zia Consultant Teleclinics, Karachi, Pakistan.
  • Department of Family Medicine, Noor e Zia Consultant Teleclinics, Karachi, Pakistan.

Zitieren

APA

Zia, S., Shamail, F., Zia, F., Zia, V., & Naeem, S. (2026). Modern approaches in asthma management: Revolutionizing severe asthma treatment with biologics. Journal of the Pakistan Medical Association, 76(06), 931-937. https://doi.org/10.47391/jpma.23160

Vancouver

Zia S, Shamail F, Zia F, Zia V, Naeem S. Modern approaches in asthma management: Revolutionizing severe asthma treatment with biologics. Journal of the Pakistan Medical Association. 2026;76(06):931-937. doi:10.47391/jpma.23160

BibTeX
@article{Zia2026,
  author = {Zia, Shamail and Shamail, Farozaan and Zia, Fazail and Zia, Vardah and Naeem, Shamsa},
  title = {Modern approaches in asthma management: Revolutionizing severe asthma treatment with biologics},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  volume = {76},
  number = {06},
  pages = {931--937},
  doi = {10.47391/jpma.23160}
}
Kostenlos starten →